How is Machine Learning Accelerating Drug Discovery?
Written by Abhishek Shankhwar
Machine Learning Offers A Good Solution in Accelerating Drug Discovery:
Machine learning offers effective and efficient access and understanding of the vast amount of chemical data, and this ultimately improves the processes and outcomes. Machine learning can automate all the predictions and experiments. Big data and machine learning can generate a value of up to 100 billion dollars annually. It also helps with cost and timeframes. It can quickly estimate the binding affinities between the candidate taking the drug and the target. It has been proven that drugs can work only if they stick to their target proteins in the body. As we already discussed above, machine learning does an excellent job in accelerating drug discovery. It has presented a good opportunity to the contract research organizations as well as pharmaceutical companies since these firms invest a lot of time and resources in drug discovery.Conclusion:
In simple words, you can say that drug development is important for future generations as well as the present ones. And with the help of machine learning, this process has become quite effective, less costly, and less time-consuming. Machine learning is accelerating drug discovery. Machine learning is life-changing for the drug discovery process. It makes the process much easier now.Article author
About the Author
Further reading
Further Reading
Article
Ultimate Guide to Finding the Best Massage for Stress Relief
Introduction In today's fast-paced and demanding world, stress has become a common part of our lives. Whether it's due to work pressures, personal relationships, or financial worries, stress can take a toll on our physical and mental well-being. That's why finding effective ways to relieve stress is crucial for maintaining a healthy and balanced life. One such method that has been proven to be highly effective is massage therapy . Massage not only provides relaxation and reli
August 30, 2023
Article
New T-cell vaccine against SARS-CoV-2 mutant strains
A research team from China has developed an mRNA-based T-cell-inducing antigen vaccine that strengthens the COVID-19 vaccine against SARS-CoV-2 variants. Herd immunity through mass vaccination is an effective way to prevent infectious diseases. However, the common SARS-CoV-2 mutant strains have largely escaped the humoral immunity induced by the COVID-19 vaccine, which was developed on the basis of the S protein. On May 23, 2023, a research team from Shenzhen Bay Laboratory,
June 25, 2023
Article
The control of COVID-19 may require regular booster vaccinations
Most people today are immune to SARS-CoV-2, the coronavirus that causes COVID-19, thanks to widespread vaccination campaigns and unplanned infection. Although this widespread immunity hasn't stopped new infections from happening, it has slowed the devastating spread of illness and death that the initial COVID-19 epidemic caused. As the virus evolves and produces novel strains that can partially dodge vaccines and antibodies created by past infections, it is imperative that t
June 25, 2023